MOXIVIB CV DRY SYRUP WFR (DPCO) "AMOXYCILLIN 200mg. IP + CLAVULANIC ACID 28.5mg. IP

Moxivib CV Dry Syrup WFR is an amoxycillin and clavulanic acid syrup used for susceptible bacterial infections. Main uses: lower respiratory tract infections caused by susceptible bacteria that make beta-lactamase, including H. influenzae and M. catarrhalis; acute bacterial otitis media (middle ear infection) caused by susceptible beta-lactamase-producing bacteria; sinusitis caused by susceptible beta-lactamase-producing bacteria; skin and skin structure infections caused by susceptible beta-lactamase-producing bacteria; urinary tract infections caused by susceptible beta-lactamase-producing bacteria.

Common side effects of Moxivib CV Dry Syrup WFR include diarrhoea or loose stools; nausea; skin rash and hives (urticaria); vomiting; headache; abdominal discomfort and gas. Get medical help at once if you notice serious allergic reactions, including anaphylaxis; severe skin reactions such as Stevens-Johnson syndrome; liver problems, hepatitis and cholestatic jaundice.

Moxivib CV Dry Syrup WFR contains Amoxycillin 200 mg + Clavulanic Acid 28.5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Moxivib CV Dry Syrup WFR only as your doctor advises.

The MRP of Moxivib CV Dry Syrup WFR is ₹65.2 for a pack of 30ml. For chemists and distributors, the PTR is ₹49.68 and the PTS is ₹44.71.

Moxivib CV Dry Syrup WFR contains Amoxycillin 200 mg + Clavulanic Acid 28.5 mg. It comes in a pack of 30ml.

In this combination, Amoxycillin acts on susceptible bacteria by blocking the formation of their cell walls. Clavulanic Acid guards the antibiotic by inhibiting the beta-lactamase enzymes that certain bacteria release to destroy it. This paired action is what gives the syrup its antibacterial activity against beta-lactamase-producing strains.

Must not be used if there has been a serious allergic reaction (such as anaphylaxis or Stevens-Johnson syndrome) to amoxycillin, clavulanic acid or other penicillins and cephalosporins. Must not be used if there has been cholestatic jaundice or liver problems earlier with this amoxycillin-clavulanic acid combination. Use should be avoided in patients with mononucleosis (glandular fever), as a skin rash is likely. Check with a doctor first if the patient has liver impairment or a history of penicillin allergy. Check with a doctor first if diarrhoea occurs during or after treatment.

Moxivib CV Dry Syrup WFR is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.